Summary of Significant Accounting Policies - Additional Information (Detail)		12 Months Ended
	Mar. 04, 2022 shares	Dec. 31, 2023 USD ($) ReportingUnit Segment shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 14, 2023 USD ($)	Jul. 31, 2019 USD ($)	Jul. 19, 2019 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Denominator for diluted earnings per share - adjusted weighted average shares used in computing net income per share - diluted | shares		56,377	57,455	57,264
Charges associated with convertible debt instruments, net of tax		$ 0	$ 387,000	$ 0
Cash and cash equivalents, beginning of period		$ 523,458,000	$ 603,814,000	$ 717,292,000
Common stock excluded from calculation of diluted earnings per share | shares		306,849	177,318	68,968
Dilutive effect on shares of conversion premium | shares			1,359,957
Advertising Expense		$ 800,000	$ 600,000	$ 600,000
Revenue		638,764,000	801,536,000	670,534,000
Contingent Consideration Obligation Estimated		$ (30,600,000)	(28,700,000)
Number of reporting units | ReportingUnit		1
Reason for change in impairment assessment date		The change is being made to better align the annual impairment assessment date with the Company's annual planning and budgeting process as well as long-term planning and forecasting process.
Impairment assessment date		October 1, 2024
Impairment to goodwill		$ 0	0	0
Impairment charges		0	0	0
Impairment of intangible assets		$ 0
Number of operating segments | Segment		1
Sales Revenue
Summary Of Significant Accounting Policies [Line Items]
Revenue		$ 0	0
Sales Revenue | Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Revenue		0	0
Accounting Standards Update 2020-06
Summary Of Significant Accounting Policies [Line Items]
Denominator for diluted earnings per share - adjusted weighted average shares used in computing net income per share - diluted | shares	3,474,429
Charges associated with convertible debt instruments, net of tax			400,000
0.375% Convertible Senior Notes due 2024
Summary Of Significant Accounting Policies [Line Items]
Aggregate principal amount					$ 69,700,000	$ 287,500,000	$ 287,500,000
Principal amount		69,700,000	287,470,000		217,700,000
1.00% Convertible Senior Notes due 2028
Summary Of Significant Accounting Policies [Line Items]
Aggregate principal amount		600,000,000			290,100,000
Principal amount		$ 600,000,000	$ 0		309,900,000
Cash					$ 290,100,000
Minimum | Sales Revenue | Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		10.00%	10.00%
Restricted Stock Units and Performance Stock Units | Awards Granted to Executive Level Employees
Summary Of Significant Accounting Policies [Line Items]
Estimated forfeiture rates		3.00%
Restricted Stock Units and Performance Stock Units | Awards Granted to Non-Executive Level Employees
Summary Of Significant Accounting Policies [Line Items]
Estimated forfeiture rates		8.00%
Non-Employee Directors
Summary Of Significant Accounting Policies [Line Items]
Estimated forfeiture rates		0.00%
Employee Stock Option [Member] | Awards Granted to Executive Level Employees
Summary Of Significant Accounting Policies [Line Items]
Estimated forfeiture rates		3.00%
Employee Stock Option [Member] | Awards Granted to Non-Executive Level Employees
Summary Of Significant Accounting Policies [Line Items]
Estimated forfeiture rates		8.00%
Pfizer
Summary Of Significant Accounting Policies [Line Items]
Revenue				$ 68,300,000
Pfizer | Sales Revenue | Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage				10.00%
Pfizer | Minimum | Sales Revenue | Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage				10.00%
Customer Number One | Accounts Receivable | Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		10.00%	10.00%
Purolite | Accounts Receivable | Customer Concentration Risk [Member]
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage			12.70%